HIV Clinical Trial
Official title:
A Prospective, Randomized, Open Label, Trial Comparing the PrePex™ Device to Surgical Circumcision for Rapid Scale Up of Male Circumcision in Resource Limited Settings
The World Health Organization and UNAIDS cite that male circumcision can reduce the lifetime
risk of HIV infection by 60% in high risk areas such as Sub Saharan Africa.
Rwanda has a national plan to offer a voluntary circumcision program to 2 million adult men
in 2 years as part of a comprehensive HIV prevention package. To achieve this goal, the
government is continuing to study the PrePex™ device, developed to enable rapid adult male
circumcision in resource limited settings.
The study will enroll one hundred and fifty (150) persons scheduled for voluntary
circumcision. The subjects will be randomly divided into two unbalanced study arms, PrePex™
arm which will include about a hundred and twenty (100) subjects and surgical circumcision
arm which will include about sixty (50) subjects.
Study duration per subject will be 9 weeks.
The World Health Organization and UNAIDS cite that male circumcision can reduce the lifetime
risk of HIV infection by 60% in high risk areas such as Sub Saharan Africa. In 2009, the US
Government (USAID) reported that scaling up male circumcision to reach 80 percent of adult
and newborn males in 14 African countries by 2015 could potentially avert more than 4
million adult HIV infections between 2009 and 2025 and yield annual cost savings of US$1.4 -
1.8 billion after 2015, with a total net savings of US$20.2 billion between 2009 and 2025.
There are over 38 million adolescent and adult males in Africa that could benefit from male
circumcision for HIV prevention. The challenge Africa faces is how to safely scale up a
surgical procedure in resources limited settings.
The government of Rwanda has a national plan to decrease the incidence rate of HIV by 50%,
and to support this, needs to conduct 2 million voluntary adult male circumcisions in 2
years, a nearly impossible goal with surgical methods. Hence, the government embarked upon a
pre-safety and pivotal study to test The PrePex™ System, a new device and methodology for
rapid adult male circumcision in resource limited settings. Evidence showed the safety and
efficacy of the device, as well as the ability to conduct the procedure with no anesthesia,
no blood, no sutures and in a standard consultation room.
The government decided to embark upon a controlled, randomized, two arm study comparing the
PrePex™ device with the surgical method to have a broader evidence base to support the
findings in the pivotal study.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |